MedAdvisor Limited (ASX:MDR)
Australia · Delayed Price · Currency is AUD 0.0830
+0.0080 (10.67%)
Jul 21, 2025, 3:17 PM AEST
MedAdvisor Revenue
MedAdvisor had revenue of 57.11M AUD in the half year ending December 31, 2024, a decrease of -10.88%. This brings the company's revenue in the last twelve months to 103.66M, down -5.27% year-over-year. In the fiscal year ending June 30, 2024, MedAdvisor had annual revenue of 122.11M with 24.64% growth.
Revenue (ttm)
103.66M
Revenue Growth
-5.27%
P/S Ratio
0.45
Revenue / Employee
n/a
Employees
n/a
Market Cap
46.86M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 122.11M | 24.14M | 24.64% |
| Jun 30, 2023 | 97.96M | 30.21M | 44.60% |
| Jun 30, 2022 | 67.75M | 28.98M | 74.74% |
| Jun 30, 2021 | 38.77M | 29.17M | 303.77% |
| Jun 30, 2020 | 9.60M | 1.36M | 16.51% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Ramsay Health Care | 17.12B |
| Telix Pharmaceuticals | 783.21M |
| Ansell | 3.00B |
| Mesoblast | 9.16M |
MedAdvisor News
- 5 months ago - Half Year 2025 MedAdvisor Ltd Earnings Presentation Transcript - GuruFocus